A big new study suggests that certain genetic traits—like insomnia risk and neuroticism—may make depression harder to treat, ...
Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics (BNGO), announced that Centers for Medicare & Medicaid Services, CMS, posted ...
LONDON, GREATER LONDON, UNITED KINGDOM, September 12, 2025 /EINPresswire.com/ -- What Is The Omics-Based Clinical Trials Market Size And Growth? In recent times, the omics-based clinical trials market ...
LONDON, GREATER LONDON, UNITED KINGDOM, September 12, 2025 /EINPresswire.com/ -- Genetic Analysis Market Growth Forecast: What To Expect By 2025? The market size for genetic analysis has seen a swift ...
Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China Background: Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) marked by persistent inflammation and ...
Judge Amit P. Mehta said the company must hand over some of its search data to rivals, but did not force other big changes the U.S. wanted. By David McCabe David McCabe has covered the Google search ...
Butte, A. (2002) The use and analysis of microarray data. Nature Reviews Drug Discovery, 1, 951-960.
ABSTRACT: DNA microarray is a widely used technique which allows one to identify the genes that are similarly or differentially expressed in different cell types or conditions, to learn how their ...
Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.
SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced the release of the latest versions of its VIA™ and Solve™ software for genomic data analysis and ...
Abstract: Microarray platforms such as Gene expression, oligonucleotide (GeneChip), and cDNA (complementary DNA) can play a critical role in the understanding of genome sequencing, by providing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback